| |
| Publications: |
A Guide to the Clinical Care of Women with HIV/AIDS, 2005 edition |
<
Previous
| Home | Next >
Indexes
Index of Topics Nos– A– B–
C– D– E–
F–G–H–
I– J– K–
L
M– N–
O– P– Q–
R– S– T–
U– V– W– X–Y– Z
Nos TOP
A
TOP
| abnormal uterine bleeding |
| access to care |
| acute illness |
| adherence |
| |
| |
counseling during pregnancy |
| |
and depression |
| |
improvement, table |
| |
measures of |
| |
predictors |
| |
special populations |
| adolescents |
| |
and adherence |
| |
care requirements |
| |
epidemiology |
| |
interview menmonic (table) |
| |
pregnancy counseling |
| Adult Aids Clinical Trial Group |
| advance care planning |
| |
counseling during pregnancy |
| |
at end of life |
| adverse effects |
| African American patients |
| AIDS |
| |
incidence in US |
| |
progression likelihood |
| AIDS Alliance for Children, Youth & Families |
| AIDS-defining illness (table) |
| AIDS dementia complex |
| |
incidence |
| |
management |
| AIDS Education and Training Centers |
| AIDS Education Global Information System |
| AIDS Info NYC |
| AIDS Risk Reduction model |
| AIDS Treatment Data Network |
| AIDSInfo |
| AIDSMeds.com |
| alcohol |
| alcohol addiction |
| alcohol intoxication |
| allergies, topical |
| altered status |
| amenorrhea |
| American Academy of HIV Medicine |
| American College of Obstetricians and Gynecologists |
| American Foundation for AIDS Research |
| American Psychological Association Office on AIDS |
| amniocentesis |
| anal squamous intraepithelial lesions |
| anemia |
| |
management |
| |
during pregnancy, nutritional aspects |
| anovulation |
| antioxidants |
| Antiretroviral Pregnancy Registry, and pregnancy |
| anxiety |
| |
medications (table) |
| |
misperceptions (table) |
| aphthous ulcers |
| |
genital (image) |
| |
genital, management |
| |
oral (image) |
| ARV therapy. see also individual drugs and classes in drugs index |
| |
adverse events |
| |
adverse fetal effects |
| |
adverse maternal effects |
| |
adverse pregnancy effects |
| |
agents |
| |
indications (table) |
| |
initial regimens (table) |
| |
interactions with psychotropics (table) |
| |
intrapartum |
| |
in neonates |
| |
nutritional considerations, and patients |
| |
nutritional counseling |
| |
perinatal HIV transmission |
| |
for postexposure prophylaxis (table) |
| |
pregnancy, pharmacokinetics during, table |
| |
pregnancy, use during, table |
| |
principles |
| |
principles, during pregnancy, table |
| |
regimen change after treatment failure (table) |
| |
in substance abusers |
| |
treatment guidelines |
| Asia |
| Association of Nurses in AIDS Care |
| assumptions (table) |
| atypical glandular cells |
| avascular necrosis |
B
TOP
C TOP
| Canadian AIDS Treatment Information Exchange |
| candidiasis |
| |
images |
| |
management, and vaginal discharge, table |
| |
during pregnancy |
| CD4 count |
| |
associated complications (table) |
| |
baseline evaluation |
| |
perinatal transmission |
| |
in pregnancy |
| |
testing, during pregnancy |
| CD4 subset analysis (table) |
| CDC Division of HIV/AIDS Prevention |
| CDC National Prevention Information Network |
| cervical cancer |
| |
in Brazil |
| |
in HIV patients |
| |
prevalence in Zambia |
| cervical caps |
| cervical dysplasia |
| cervical ectopy (table), and HIV s usceptibility |
| cervical intrepithelial neoplasia (image) |
| cervical lesions |
| cervicitis (image) |
| cervix development |
| cesarean delivery, and Intrapartum |
| chancres (image) |
| chancroid |
| |
image |
| |
management |
| chemistry panel |
| childbearing imperative |
| children, and adherence |
| chlamydia |
| |
image |
| |
management |
| chorioamnionitis |
| chorionic villus sampling |
| chronic care model |
| circumcision |
| clinical failure |
| clinical services pyramid |
| cocaine addiction |
| cocaine use |
| coccidiomycosis |
| colorectal cancer |
| colposcopy |
| |
genital warts |
| |
recommendations (table) |
| comfort, at end of life |
| communication |
| |
across culture, table |
| |
breaking bad news |
| |
at end of life |
| |
essentials of |
| |
and risk assessment |
| |
risk reduction counseling |
| communicating about (table) |
| Community Program for Clinical Research on AIDS |
| complementary therapies |
| |
communicating about (table) |
| |
at end of life |
| concomitant illness |
| condoms |
| |
counseling during pregnancy |
| |
practices in Brazil |
| |
practices in Zambia |
| |
as prevention tool |
| |
use influences (table), table |
| condoms (female), table |
| condoms (male) |
| |
characteristics (table) |
| |
HIV transmission |
| condyloma latum (image) |
| condylomata acuminata (image) |
| confidentiality |
| |
and adolescents |
| |
essentials of |
| consultations |
| context, in communication |
| contraception |
| |
access in Brazil |
| |
communicating about |
| |
counseling during pregnancy |
| |
effect on transmission (table) |
| |
HIV transmission |
| |
and HIV transmission |
| |
methods (table) |
| |
motivations |
| |
prevention effectiveness (table) |
| contraction stress testing |
| core values |
| |
African American culture |
| |
Hispanic culture |
| cough |
| counseling |
| |
about testing, table |
| |
of adolescents |
| |
after occupational exposure |
| |
essentials of |
| |
influence on prevention |
| |
initial visit |
| |
in practice |
| |
during pregnancy |
| |
pregnant patients |
| counselors |
| Critical Path AIDS Project |
| Crohn’s disease |
| cryptococcosis |
| Cryptococcus neoformans |
| |
management |
| |
prophylaxis (table) |
| cultural competence |
| |
at end of life |
| |
risk reduction counseling |
| |
treating HIV patients |
| cyryptosporidiosis |
| cytomegalovirus |
| |
baseline evaluation |
| |
management, and gynecological problems |
| |
during pregnancy, and opportunistic infections |
| |
prophylaxis (table) |
D TOP
E TOP
F TOP
G TOP
H TOP
I TOP
J TOP
K TOP
L TOP
M TOP
N TOP
O TOP
P TOP
| pain |
| |
| |
scope of |
| pain relief |
| |
barriers, table |
| |
principles |
| |
WHO ladder (table) |
| Pap smears |
| |
abnormal, management of (table) |
| |
anal, technique |
| |
baseline evaluation |
| |
recommendations |
| |
use, table |
| papillomavirus |
| |
image |
| |
during pregnancy |
| Partnership for Caring |
| patient education |
| patient evaluation |
| |
follow-up visits |
| |
initial visit |
| |
intake flow sheet |
| Pediatric AIDS Clinical Trials Group |
| Pediatric Classification System (table) |
| pelvic examination |
| pelvic inflammatory disease |
| |
image |
| |
IUD use |
| |
management |
| pelvic mass |
| pelvic pain |
| percutaneous umbilical blood sampling |
| perimenopause |
| perinatal transmission |
| |
in Brazil |
| |
factors |
| |
prevention regimen comparison (table) |
| |
prevention strategies |
| |
trials review, table |
| peripheral neuropathy |
| pH (vaginal) (table), |
| pharmacokinetics |
| |
ARV/psychotropics interactions (table) |
| |
during pregnancy, table |
| |
in pregnancy |
| physical examination |
| placental abruption |
| pneumococcal vaccine |
| Pneumocystis carinii pneumonia |
| |
as diagnostic marker |
| |
management |
| |
neonatal prophylaxis |
| |
during pregnancy, table |
| |
prophylaxis (table) |
| polio vaccine |
| polymerase chain reaction (PCR) |
| Population Council |
| postexposure prophylaxis |
| |
mucous membrane exposure (table) |
| |
percutaneous exposure (table) |
| |
after sexual contact |
| |
site management |
| postpartum care |
| poverty |
| |
access to care |
| |
among adolescents |
| |
in Brazil |
| |
and seeking care |
| |
treatment barrier in Zambia |
| pregnancy |
| |
adverse outcomes (table) |
| |
adverse outcomes, ARV therapy |
| |
among adolescents |
| |
antepartum history |
| |
ARV pharmacokinetics, table |
| |
ARV therapy during, table |
| |
drug categories (table) |
| |
drug pharmacokinetics |
| |
HIV natural history |
| |
laboratory evaluation (table) |
| |
nutritional status during |
| |
and postexposure prophylaxis |
| |
substance abuse |
| |
testing |
| |
vs. amenorrhea |
| prenatal care |
| |
in Brazil |
| |
nutritional counseling |
| preterm delivery |
| prevention messages |
| prevention models |
| priorities (table) |
| prisons, substance abusers in |
| prognosis |
| |
in depressed patients |
| |
determining |
| progressive multifocal leukoencephalopathy |
| Project Inform |
| provider-patient relationship |
| |
and adherence, table |
| |
cautions for providers |
| |
communication across culture, table |
| providers |
| pruritus |
| psychosis |
| |
medications (table) |
| |
misperceptions (table) |
| psychosocial issues |
| |
among adolescents |
| |
at diagnosis |
| |
intervention suggestions |
| puberty |
| pyosalpinx |
Q TOP
R TOP
S TOP
T TOP
U TOP
V TOP
W TOP
X TOP
Y TOP
Z TOP
|
